Segment & Geographic Data Reported Filing Data API & CSV Delivery

Description of Quantum Si Incorporated's Business Segments

Quantum Si Incorporated's reported revenue by business segment and by geographic region, normalized against the consolidated income statement. Free below: current-quarter segment and regional revenue mix. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of Q2 ((Jun 30 2026))
Segments Reported
2
Business segments, this quarter
Largest Segment
Product
154.1% of revenue
Total Segment Revenue
$ 1
Millions, this quarter
Regions Reported
2
Geographic regions, this quarter
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Revenue Share by Business Segment — Q2 ((Jun 30 2026))

154%largest
  • Product154.1%
  • International Sales96.5%

Revenue by Business Segment — Q2 ((Jun 30 2026))

SegmentPeriodRevenue
(Millions)
% of TotalOperating Income
Product Q2 ((Jun 30 2026)) $ 1 154.1%
International Sales Q2 ((Jun 30 2026)) $ 0 96.5%

Revenue Share by Region — Q2 ((Jun 30 2026))

73%largest
  • United States72.9%
  • Non-US27.1%

Revenue by Geographic Region — Q2 ((Jun 30 2026))

RegionPeriodRevenue
(Millions)
% of Total
United States Q2 ((Jun 30 2026)) $ 0 72.9%
Non-US Q2 ((Jun 30 2026)) $ 0 27.1%

Quantum Si Incorporated's Business Overview

Quantum-Si Incorporated is a biotech company that has made significant strides in the development of next-generation protein sequencing technologies. This innovative approach has the potential to revolutionize fields such as genomics, proteomics, and personalized medicine. Below are the various segments, products, and services offered by Quantum-Si:

Segments

1. Applications in Research and Development
- Quantum-Si provides powerful tools that enable researchers in academic, pharmaceutical, and biotech sectors to explore protein structures and functions more comprehensively.

2. Clinical Diagnostics
- The companys technology aims to enhance the capabilities of clinical laboratories to analyze protein expression and modification, allowing for improved disease diagnostics and monitoring.

3. Pharmaceutical Development
- Quantum-Si is positioned to assist pharmaceutical companies in drug discovery and development by providing insights into protein interactions, post-translational modifications, and other key biochemical processes.

4. Agricultural Biotechnology
- Leveraging protein analysis can aid in the development of crops with desirable traits, thus impacting agricultural industries positively through enhanced yield, disease resistance, and nutrient profiles.

Products

1. Proteomics Platforms
- ProteoMiner: A high-throughput protein sequencing platform that allows researchers to analyze complex protein samples quickly and accurately. It employs advanced technologies to increase the depth and breadth of proteomic analysis.
- Quantum Sequencer: The flagship instrument that utilizes silicon-based technology for rapid and cost-effective protein sequencing. This platform is designed for robustness and scalability, catering to both small labs and large-scale operations.

2. Reagents and Consumables
- Quantum-Si offers a suite of reagents necessary for protein labeling, sample preparation, and various assays tailored for their sequencing technologies. These consumables ensure optimal performance and reproducibility across experiments.

3. Software for Data Analysis
- Advanced software solutions designed for data acquisition, interpretation, and visualization of protein sequences and structures. These tools enable researchers to manipulate and analyze large datasets, apply machine learning algorithms, and collaborate effectively.

Services

1. Custom Protein Sequencing Services
- Quantum-Si provides bespoke services to academic and industrial partners requiring detailed protein analysis. This includes sample preparation, sequencing, and data analysis tailored to specific research needs.

2. Training and Support
- Comprehensive training programs designed to familiarize clients with the technology, protocols, and data interpretation methods. Additionally, ongoing technical support is offered to help users optimize their experimental workflows.

3. Partnership Opportunities
- The company is open to collaborations with academic institutions, healthcare organizations, and other biotech firms for joint research projects that leverage their innovative sequencing technology. This collaboration model can include co-development agreements and shared access to proprietary technologies.

4. Consulting Services
- Quantum-Si offers consulting services to help organizations strategize on the implementation of protein analysis in their research programs. This includes guidance on experimental design, data interpretation, and technology integration into existing workflows.

Conclusion

Quantum-Si Incorporated is at the forefront of advancing protein sequencing technology, making notable contributions to various fields such as personalized medicine, drug discovery, agricultural biotechnology, and beyond. Through its range of products and comprehensive service offerings, the company aims to empower researchers and industries to unlock the complexities of protein biology.